Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Cellectar Receives FTD for Diffuse Large B-Cell Lymphoma Treatment

contractpharmaJuly 10, 2019

Tag: Cellectar , FTD , B-Cell , lymphoma

PharmaSources Customer Service